14.7 C
Sydney
Tuesday, June 28, 2022
- Advertisement -spot_img

TAG

Actinogen Medical

Millions could benefit after breakthrough Alzheimer’s treatment trial by Aussie biotech

Biotechnology company Actinogen Medical has announced positive results for their lead drug Xanamem taking the ASX-listed company a step closer to creating a novel treatment for a disease that impacts more than 400,000 elderly Australians.

Latest news

- Advertisement -spot_img
Processing...
Thank you! Your subscription has been confirmed. You'll hear from us soon.
Email newsletter sign-up
ErrorHere